161 related articles for article (PubMed ID: 23695971)
1. Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.
Wang GK; Russell G; Wang SY
Channels (Austin); 2013; 7(4):263-74. PubMed ID: 23695971
[TBL] [Abstract][Full Text] [Related]
2. Inactivation-deficient human skeletal muscle Na+ channels (hNav1.4-L443C/A444W) in stably transfected HEK-293 cells.
Wang SY; Moczydlowski E; Wang G
Recept Channels; 2004; 10(3-4):131-8. PubMed ID: 15512848
[TBL] [Abstract][Full Text] [Related]
3. Irreversible block of cardiac mutant Na+ channels by batrachotoxin.
Wang SY; Tikhonov DB; Mitchell J; Zhorov BS; Wang GK
Channels (Austin); 2007; 1(3):179-88. PubMed ID: 18690024
[TBL] [Abstract][Full Text] [Related]
4. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Wang GK; Wang SY
Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.
Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M
Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482
[TBL] [Abstract][Full Text] [Related]
6. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
[TBL] [Abstract][Full Text] [Related]
7. Serine-401 as a batrachotoxin- and local anesthetic-sensing residue in the human cardiac Na+ channel.
Wang SY; Tikhonov DB; Zhorov BS; Mitchell J; Wang GK
Pflugers Arch; 2007 May; 454(2):277-87. PubMed ID: 17205354
[TBL] [Abstract][Full Text] [Related]
8. State-dependent block of wild-type and inactivation-deficient Na+ channels by flecainide.
Wang GK; Russell C; Wang SY
J Gen Physiol; 2003 Sep; 122(3):365-74. PubMed ID: 12913091
[TBL] [Abstract][Full Text] [Related]
9. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na
Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin Causes a Novel Proarrhythmic Syndrome.
Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels.
Stoetzer C; Voelker M; Doll T; Heineke J; Wegner F; Leffler A
Anesth Analg; 2017 Jan; 124(1):52-60. PubMed ID: 27861438
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
13. Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids.
Xiao YF; Ma L; Wang SY; Josephson ME; Wang GK; Morgan JP; Leaf A
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C362-70. PubMed ID: 16207794
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the cardiac sodium channel Na
Matasic DS; Yoon JY; McLendon JM; Mehdi H; Schmidt MS; Greiner AM; Quinones P; Morgan GM; Boudreau RL; Irani K; Brenner C; London B
J Mol Cell Cardiol; 2020 Apr; 141():70-81. PubMed ID: 32209328
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent block and resurgent tail currents induced by mouse beta4(154-167) peptide in cardiac Na+ channels.
Wang GK; Edrich T; Wang SY
J Gen Physiol; 2006 Mar; 127(3):277-89. PubMed ID: 16505148
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
Baczko I; Liknes D; Yang W; Hamming KC; Searle G; Jaeger K; Husti Z; Juhasz V; Klausz G; Pap R; Saghy L; Varro A; Dolinsky V; Wang S; Rauniyar V; Hall D; Dyck JR; Light PE
Br J Pharmacol; 2014 Jan; 171(1):92-106. PubMed ID: 24102184
[TBL] [Abstract][Full Text] [Related]
17. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
Wang GK; Calderon J; Wang SY
Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
[TBL] [Abstract][Full Text] [Related]
18. The effects of A-803467 on cardiac Nav1.5 channels.
Han Z; Jiang Y; Xiao F; Cao K; Wang DW
Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.
Bannister ML; Thomas NL; Sikkel MB; Mukherjee S; Maxwell C; MacLeod KT; George CH; Williams AJ
Circ Res; 2015 Apr; 116(8):1324-35. PubMed ID: 25648700
[TBL] [Abstract][Full Text] [Related]
20. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action.
Beyder A; Strege PR; Reyes S; Bernard CE; Terzic A; Makielski J; Ackerman MJ; Farrugia G
Circulation; 2012 Jun; 125(22):2698-706. PubMed ID: 22565935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
